drugset
drugset / Trial / NCT00905567

Topiramate 25 mg Tablets Under Fed Conditions

NCT00905567 ↗

Phase 1 Completed 24 enrolled Teva Pharmaceuticals USA
RandomizedCrossoverOpen-label

Summary

The objective of this study was to compare the rate and extent of absorption of topiramate 25 mg tablets (test) versus Topamax® (reference) administered as 2 x 25 mg tablets under fed conditions.

Timeline

Start
2001-06
Primary completion
2001-06
Completion
2001-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Topiramate Small molecule 50 mg —

Indications

No indication recorded.